Biologics: Targets & Therapy (Mar 2024)
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy
Abstract
Pamela Soberanis Pina, Stephanie Lheureux Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, CanadaCorrespondence: Stephanie Lheureux, Princess Margaret Cancer Centre, 700 University Avenue, Toronto, M5G 1Z5, Ontario, Canada, Email [email protected]: Endometrial cancer (EC) has a high epidemiological impact with incidence and mortality rising worldwide. In recent years, the integration of the pathologic and molecular classification has provided relevant information to understand the heterogeneity in the biology of EC, which led to the evolution in the management of patients. Currently, therapeutic breakthroughs have been made in advanced EC to improve oncologic outcomes, with efforts to include patient reported outcomes. Precision and personalized medicine are under way in EC exploring different combination approaches to target cross-talk pathways, cancer cell microenvironment, and metabolic vulnerabilities and improve drug delivery. Yet, collaborative efforts are needed to face the challenges in practice by refining patient selection, ideal biomarker identification, and de-escalation of therapies according to emerging molecular and genomic features of EC.Keywords: endometrial cancer, targeted therapy, molecular targets, precision medicine
